[Granulomatous lung and systemic diseases]

Area of Science:

• Immunology
• Pulmonology
• Pathology

Context:

• Granuloma formation is a defense mechanism against persistent, uneliminable particles within phagocytes.
• This immune response evolved to localize and prevent the spread of pathogens like mycobacteria.
• Granulomatous lung diseases often present with systemic inflammation, though acute phase proteins may show minimal elevation.

Purpose:

• To provide a comprehensive overview of granuloma formation and its association with diverse lung diseases.
• To highlight the differential diagnosis of granulomatous lung diseases, emphasizing the exclusion of infectious causes like tuberculosis.
• To explore the etiological spectrum of pulmonary granulomas, encompassing autoimmune disorders, immunodeficiencies, and occupational exposures.

Summary:

• Granuloma formation is a key immune process, crucial for containing persistent intracellular pathogens but also implicated in various lung pathologies.
• Sarcoidosis is the most prevalent granulomatous lung disease, necessitating the exclusion of infectious etiologies such as tuberculosis and fungal infections.
• Pulmonary granulomas arise from autoimmune diseases (e.g., rheumatoid arthritis, GPA, EGPA), immunodeficiencies (e.g., CVID, HIV-associated syndromes), and occupational exposures (e.g., hypersensitivity pneumonitis, silicosis).

Impact:

• Enhances understanding of the complex pathophysiology underlying granulomatous lung diseases.
• Aids clinicians in the differential diagnosis and management of patients presenting with granulomatous lung conditions.
• Provides a foundation for further research into targeted therapies for specific granulomatous lung diseases.